NanoCytomics/Preora Diagnostics

NanoCytomics/Preora Diagnostics is focused on making dramatic improvements in patient survival rates and costs through the early detection of leading forms of cancer, when treatments are most effective. The company is developing and commercializing non-invasive, low-cost, easy-to-administer pre-screening tests using partial wave spectroscopy (PWS) technology developed at Northwestern University in Vadim Backman’s Biophotonics laboratory.